NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

I posted that Car-T was not approved long ago. But the reasons are clear. It was costing $1 million to treat patients and the side effects were awful, which was a huge reason for the cost. Plus it’s NOT a cure for many patients. So yeah, it is limited to patients that need it. It’s not a general treatment. It costs immense sums to treat people with car-t, it can’t be given in a community setting, side effects can kill people, and when patients have those side-effects it mushrooms the cost and there is no certainty that it will work long-term.